Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon | Zendy

Adrian M. Di Bisceglie | Zendy; Mitchell L. Shiffman | Zendy; Gregory T. Everson | Zendy; Karen L. Lindsay | Zendy; James E. Everhart | Zendy; Elizabeth C. Wright | Zendy; William M. Lee | Zendy; Anna S. Lok | Zendy; Herbert L. Bonkovsky | Zendy; Timothy R. Morgan | Zendy; Marc G. Ghany | Zendy; Chihiro Morishima | Zendy; Kristin K. Snow | Zendy; Jules L. Dienstag | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

Author(s) -

Adrian M. Di Bisceglie,

Mitchell L. Shiffman,

Gregory T. Everson,

Karen L. Lindsay,

James E. Everhart,

Elizabeth C. Wright,

William M. Lee,

Anna S. Lok,

Herbert L. Bonkovsky,

Timothy R. Morgan,

Marc G. Ghany,

Chihiro Morishima,

Kristin K. Snow,

Jules L. Dienstag

Publication year - 2008

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0707615

Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , antiviral therapy , gastroenterology , chronic hepatitis , hepatitis c , liver disease , chronic liver disease , disease , immunology , virus

In patients with chronic hepatitis C who do not have a response to antiviral treatment, the disease may progress to cirrhosis, liver failure, hepatocellular carcinoma, and death. Whether long-term antiviral therapy can prevent progressive liver disease in such patients remains uncertain.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research